Aspen Holdings - Company & Market Research Reports

Home /
Companies /
Aspen Holdings

Aspen pharma is a pharmaceutical company that produces a range of medicines that treat acute and chronic conditions. It has 60 business operations in over 50 countries The company serves pharmacies, retail pharmacy chains, hospitals, clinics, prescribing specialists, dispensing general practitioners, managed healthcare funders, and retail stores across the private and public sectors. It provides a range of products such as: antidepressants, bronchodilators for asthma, anti-inflammatory agents etc.

REFINE BY

KEYWORD

Anticoagulants - Global Strategic Business Report

 Report
April 2024
196 Pages
Global

From

€5405EUR$5,600USD£4,637GBP

Global HIV Drugs Market

 Report
June 2023
158 Pages
Global

From

€2413EUR$2,500USD£2,070GBP

Global Local Anesthesia Drugs Market Report by Drug Type, Mode of Administration, Distribution Channel, and Region 2024-2032

 Report
April 2024
135 Pages
Global

From

€3763EUR$3,899USD£3,228GBP

Global Anesthetic Drugs Market (2023-2028) Competitive Analysis, Impact of Economic Slowdown & Impending Recession, Ansoff Analysis.

 Report
February 2024
180 Pages
Global

From

€3475EUR$3,600USD£2,981GBP

Africa HIV Treatment Drugs Market 2023-2027

 Report
November 2022
120 Pages
Africa

From

€2413EUR$2,500USD£2,070GBP

NEED HELP FINDING THE RIGHT PRODUCT? Olha will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Pharmaceutical Contract Manufacturing Market by Business Segment, Type of API, Type of FDF, Type of Packaging Form, Scale of Operation, End-Users and Key Geographical Regions: Industry Trends and Global Forecasts, 2021-2030

 Report
July 2021
545 Pages
Global

From

€4632EUR$4,799USD£3,973GBP

Subcutaneous Biologics, Technologies and Drug Delivery Systems (3rd Edition), 2020-2030

 Report
April 2020
536 Pages
Global

From

€4729EUR$4,899USD£4,056GBP

Anticoagulants Market Size, Share & Trends Analysis Report By Route of Administration (Oral Anticoagulants, Injectable Anticoagulants), By Drug Category, By Application (Atrial fibrillation, Pulmonary embolism), By Region, And Segment Forecasts, 2024 - 2030

 Report
February 2024
125 Pages
Global

From

€5743EUR$5,950USD£4,926GBP

Branded Generics Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

 Report
March 2024
97 Pages
Global

From

€3500EUR$3,884USD£3,107GBP

Global Heparin Market Size, Share & Trends Analysis Report by Type, Route of Administration, Application, End-use (Outpatient, Inpatient), Source, Region, and Segment Forecasts, 2024-2030

 Report
December 2023
111 Pages
Global

From

€5743EUR$5,950USD£4,926GBP

Generic Drug Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Product Type

 Report
November 2023
101 Pages
Global

From

€3500EUR$3,884USD£3,107GBP

HIV Drugs Global Market Report 2024

 Report
February 2024
175 Pages
Global

From

€4826EUR$5,000USD£4,140GBP

Pharmaceutical Spray Drying Market (2nd Edition), 2018-2028

 Report
April 2018
200 Pages
Global

From

€3377EUR$3,499USD£2,897GBP

PharmSource - Contract Small Molecule API Manufacturing Industry by the Numbers - 2019 Edition

 Report
August 2019
44 Pages
Global

From

€4821EUR$4,995USD£4,136GBP

Global Fondaparinux Market by Product (Branded, Generics), Application (Ambulatory Surgical Centres, Clinics, Diagnostic centers) - Forecast 2024-2030

 Report
March 2024
185 Pages
Global

From

€3257EUR$3,374USD£2,794GBP

€3619EUR$3,749USD£3,104GBP

Global Thrombosis Drug Market by Drug Class (Factor Xa Inhibitor, Heparin, P2Y12 Platelet Inhibitor), Disease Type (Atrial Fibrillation, Deep Vein Thrombosis, Pulmonary Embolism), Distribution Channel - Forecast 2024-2030

 Report
March 2024
187 Pages
Global

From

€3257EUR$3,374USD£2,794GBP

€3619EUR$3,749USD£3,104GBP

$Global Heparin Market by Product Type (Low Molecular Weight Heparin, Ultra-Low Molecular Weight Heparin, Unfractionated Heparin), Route of Administration (IV Injection, Subcutaneous Injection), Application, End-User - Forecast 2024-2030 - Product Thumbnail Image$

Global Heparin Market by Product Type (Low Molecular Weight Heparin, Ultra-Low Molecular Weight Heparin, Unfractionated Heparin), Route of Administration (IV Injection, Subcutaneous Injection), Application, End-User - Forecast 2024-2030

 Report
March 2024
181 Pages
Global

From

€3257EUR$3,374USD£2,794GBP

€3619EUR$3,749USD£3,104GBP

Global Anticoagulants Market by Route of Administration (Injectable Anticoagulants, Oral Anticoagulants), Anticoagulant Drug (Betrixaban, Dabigatran, Edoxaban or Rivaroxaban), Drug Class, Application - Forecast 2024-2030

 Report
March 2024
182 Pages
Global

From

€3257EUR$3,374USD£2,794GBP

€3619EUR$3,749USD£3,104GBP

Local Anesthesia Drug Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

 Report
May 2023
98 Pages
Global

From

€3500EUR$3,884USD£3,107GBP

Global Antithrombotic Drugs Market 2023-2027

 Report
May 2023
156 Pages
Global

From

€2413EUR$2,500USD£2,070GBP

154 Results (Page 3 of 8)
- 1
- 2
- 3
- 4
- 5

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.